May 6, 2022 06:47AM Vir Biotechnology (VIR) PT Lowered to $35 at Needham & Company on sotrovimab Uncertainty, Buy Rating Maintained

Apr 4, 2022 04:02PM Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference

Apr 4, 2022 04:02PM Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference

Mar 28, 2022 06:57AM Vir Biotechnology (VIR) PT Slashed to $45 at Needham & Company on sotrovimab Issues

Mar 28, 2022 06:57AM Vir Biotechnology (VIR) PT Lowered to $45 at Needham & Company

May 27, 2021 07:10AM Vir Biotechnology (VIR) Gains EUA for Sotrovimab, Patient Use Within Weeks - Needham & Company

Apr 6, 2021 04:01PM Vir Biotechnology to Present at the 20th Annual Needham Virtual Healthcare Conference

Apr 6, 2021 04:01PM Vir Biotechnology to Present at the 20th Annual Needham Virtual Healthcare Conference

Mar 2, 2021 08:06AM Vir Biotechnology (VIR) PT Raised to $75 at Needham & Company

Sep 14, 2020 09:30AM Pre-Open Stock Movers 09/14: (IMMU) (SGMS) (NVDA) Higher; (GILD) (MGM) (WMT) Lower (more...)

Jul 10, 2020 04:01PM Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jul 10, 2020 04:01PM Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jul 8, 2020 05:59AM Vir Biotechnology Inc. (VIR) Prices 7.14M Share Common Offering at $42/Sh

Jul 7, 2020 10:25PM Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Jul 7, 2020 10:24PM Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Jul 6, 2020 07:03AM Vir Biotechnology Inc. (VIR) Announces Proposed Public Offering of Common Stock

Jul 6, 2020 07:00AM Vir Biotechnology Announces Proposed Public Offering of Common Stock

Jul 6, 2020 07:00AM Vir Biotechnology Announces Proposed Public Offering of Common Stock